Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Theravance Biopharma Sees Operating Expenses For R&D At $195M-$225M


Benzinga | Feb 23, 2021 04:21PM EST

Theravance Biopharma Sees Operating Expenses For R&D At $195M-$225M






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC